Logo-npj
J Nephropharmacol. Inpress.
doi: 10.34172/npj.2026.12783
  Abstract View: 16

Original

Ocular manifestations in chronic kidney disease; a cross-sectional study

Raed Shatnawi 1* ORCID logo, Mohammad Al-Thnaibat 2, Hamdi Alquoqa 3, Rand Altarawneh 3, Motasem Al-Latayfeh 1, Mohammad Abu Ain 1, Muhannad El-Faouri 1, Ahmad Al-Hyari 4, Husam Shatnawi 5, Yazan Shatnawi 5

1 Department of Special Surgery, Faculty of Medicine, The Hashemite University, Zarqa, Jordan
2 Department of Internal Medicine, Faculty of Medicine, The Hashemite University, Zarqa, Jordan
3 Department of Ophthalmology, Ibn Alhaitham Hospital, Amman, Jordan
4 Department of Ophthalmology, Prince Hamzah Hospital, Ministry of Health, Amman, Jordan
5 Faculty of Medicine, The Hashemite University, Zarqa, Jordan
*Corresponding Author: Raed Shatnawi, Email: raed972@yahoo.com

Abstract

Introduction: Chronic kidney disease (CKD) is a growing national health challenge that is associated with systemic complications, including eye-related morbidity, which can markedly reduce quality of life.

Objectives: This study aimed to estimate the prevalence of ocular manifestations among patients with CKD and to identify associated risk factors, including CKD stage, dialysis dependence, comorbidities, and sex.

Patients and Methods: We conducted a retrospective cross-sectional study of patients with CKD who attended a private ophthalmology clinic in Amman, Jordan. Demographic and clinical data (eGFR, CKD stage [2–5], dialysis status, and comorbidities: hypertension, diabetes, and anaemia) were extracted from records. Ocular assessment included retinal haemorrhages, cataracts, hypertensive retinopathy, macular oedema, and uremic optic neuropathy, in addition to LogMAR-based visual acuity. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated using logistic regression.

Results: Ocular manifestations were common, including hypertensive retinopathy (24.4%), retinal haemorrhages (17.1%), cataracts (14.6%), and macular oedema (7.3%). Dialysis was associated with uremic optic neuropathy (OR = 5.50) and retinal haemorrhages (OR = 2.80). Advanced CKD (stages 4–5) was associated with higher odds of retinal haemorrhages and increased risks of cataracts and hypertensive retinopathy. Diabetes was a significant predictor of retinal haemorrhages, cataracts, and hypertensive retinopathy, and hypertension was associated with more severe hypertensive retinopathy.

Conclusion: Ocular complications are common in CKD and are associated with disease severity, dialysis dependence, and systemic comorbidities. Integrating regular ophthalmologic screening into CKD care may help prevent avoidable visual impairment and improve quality of life.


Implication for health policy/practice/research/medical education:

• Retinal hemorrhages, cataracts, and hypertensive retinopathy are common among chronic kidney disease (CKD) patients, with most experiencing moderate to severe visual impairment.

• Advanced CKD stages (especially stage 5) and dialysis dependency significantly increase the risk of retinal hemorrhages and uremic optic neuropathy.

• Diabetes and hypertension are key predictors of cataracts and hypertensive retinopathy, while combined comorbidities raise the risk of multiple ocular pathologies.

• Integrating regular ophthalmologic evaluations into CKD management is critical for early detection and prevention of vision loss.

Please cite this paper as: Shatnawi R, Al-Thnaibat M, Alquoqa H, Altarawneh R, Al-Latayfeh M, Abu Ain M, El-Faouri M, Al-Hyari A, Shatnawi H, Shatnawi Y. Ocular manifestations in chronic kidney disease; a cross-sectional study. J Nephropharmacol. 2026;15(x):e12783. DOI: 10.34172/npj.2026.12783.

First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.